SCHEMBL6472763

SCHEMBL6472763

c1ccc(CN2CCC3(CC2)CNc2ncccc23)cc1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SIGMAR1 Q99720 10/20 0.52
TSHR P16473 3/20 0.52
CYP2C19 P33261 3/20 0.52
CYP3A4 P08684 3/20 0.52
TP53 P04637 2/20 0.52
CYP1A2 P05177 2/20 0.52
CYP2D6 P10635 2/20 0.52
ALDH1A1 P00352 2/20 0.52
CYP2C9 P11712 2/20 0.52
DRD2 P14416 1/20 0.50
NFKB1 P19838 1/20 0.50
HTR2A P28223 1/20 0.50
HTR2C P28335 1/20 0.50
MAPK1 P28482 1/20 0.50
HTR2B P41595 1/20 0.50
MTOR P42345 1/20 0.50
MEN1 O00255 2/20 0.49
KMT2A Q03164 2/20 0.49
BLM P54132 1/20 0.49
PMP22 Q01453 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6215031 0.86 SIGMAR1 (0.57) SIGMAR1TSHRCYP3A4ALDH1A1CYP2C9
SCHEMBL30411839 0.82 SIGMAR1 (0.47) SIGMAR1TSHRCYP2C19CYP3A4TP53
SCHEMBL23595010 0.82 SIGMAR1 (0.47) SIGMAR1TSHRCYP2C19CYP3A4TP53
SCHEMBL6523543 0.82 SIGMAR1 (0.41) SIGMAR1TSHRCYP2C19CYP3A4TP53
SCHEMBL6422849 0.81 SIGMAR1 (0.57) SIGMAR1TSHRCYP2C19CYP3A4TP53
SCHEMBL31212132 0.78 OTUD7B (0.40) CYP2C19CYP3A4CYP1A2KMT2A
SCHEMBL18181144 0.78 OTUD7B (0.40) CYP2C19CYP3A4CYP1A2KMT2A
SCHEMBL10152976 0.77 OTUD7B (0.42) SIGMAR1DRD2NFKB1HTR2AHTR2C
SCHEMBL2381131 0.77 OPRL1 (0.57) SIGMAR1TSHRCYP2C19CYP3A4TP53
SCHEMBL20608087 0.77 OTUD7B (0.61) SIGMAR1TSHRCYP3A4CYP2D6DRD2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050153998-A1 Tetrahydroisoquinoline or isochroman compounds ITO FUMITAKA (JP) 2005-07-14 US disclosed
WO-2005016913-A1 TETRAHYDROISOQUINOLINE OR ISOCHROMAN COMPOUNDS AS ORL-1 RECEPTOR LIGANDS FOR THE TREATMENT OF PAIN AND CNS DISORDERS PFIZER JAPAN, INC. (JP) 2005-02-24 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050153998-A1 Tetrahydroisoquinoline or isochroman compounds OPRL1, NR1H3, HRH3 SIGMAR1 11/4885TSHR 1589/4885CYP2C19 1159/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.